CYP vs PAR

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

CYP

CYNATA THR FPO [CYP]

49LOW

PAR

PARA BIO FPO [PAR]

49LOW

Score Breakdown

CYP PAR
Technical
60
58
Catalyst
50
67
Sentiment
50
50
Fundamental
35
48
Momentum
67
46
Risk Gate
42
50

Key Metrics

CYP Metric PAR
$73.6MMarket Cap$115.7M
184KAvg Volume (20d)881K
N/AShort Interest+0.4%
$0.43552-Week High$0.480
$0.14052-Week Low$0.240
+1.7%Daily Change+0.8%
$0.305Entry Price$0.257
-113.0%ROE-180.2%
N/AProfit MarginN/A

Active Signals

CYP Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.2x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.3 quarters)
●4C filed 2026-01-28
●Revenue declining (-10%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 4.8% over the last 5 days
●Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk

Ask Scout AI to compare CYP and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CYP Full Analysis → PAR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).